Immunopharmacology of CpG oligodeoxynucleotides and ribavirinVOLLMER, Jörg; RANKIN, Robert; HARTMANN, Hanna et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2314-2317, issn 0066-4804, 4 p.Article

Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. CommentaryBLANCHE, Stéphane; TARDIEU, Marc; BENHAMMOU, Valérie et al.AIDS (London). 2006, Vol 20, Num 13, issn 0269-9370, 1685-1690,1777-1778 [8 p.]Article

Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogsLUND, Kaleb C; PETERSON, Larae L; WALLACE, Kendall B et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2531-2539, issn 0066-4804, 9 p.Article

Viral error catastrophe by mutagenic nucleosidesANDERSON, Jon P; DAIFUKU, Richard; LOEB, Lawrence A et al.Annual review of microbiology. 2004, Vol 58, pp 183-205, issn 0066-4227, 23 p.Article

Safety issues related to the administration of ribavirin : An update on respiratory syncytial virusKRILOV, Leonard R.The Pediatric infectious disease journal. 2002, Vol 21, Num 5, pp 479-481, issn 0891-3668Article

Parainfluenza type 3 infection post stem cell transplant : high prevalence but low mortalityDIGNAN, F; ALVARES, C; RILEY, U et al.The Journal of hospital infection. 2006, Vol 63, Num 4, pp 452-458, issn 0195-6701, 7 p.Article

Mitochondrial toxicity of nucleoside analogues in primary human lymphocytesSETZER, Bernhard; SCHLESIER, Michael; THOMAS, Anna K et al.Antiviral therapy (London). 2005, Vol 10, Num 2, pp 327-334, issn 1359-6535, 8 p.Article

Mitochondrial toxicity and HIV therapyWHITE, Alex J.Sexually transmitted infections. 2001, Vol 77, Num 3, pp 158-173, issn 1368-4973Article

DidanosineLa Revue Prescrire. 2000, Vol 20, Num 209, issn 0247-7750, p. 587Article

Antiadenovirus activities of several classes of nucleoside and nucleotide analoguesNAESENS, L; LENAERTS, L; ANDREI, G et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 3, pp 1010-1016, issn 0066-4804, 7 p.Article

An improved method for the synthesis of nucleoside triphosphate analoguesMOHAMADY, Samy; JAKEMAN, David L.Journal of organic chemistry. 2005, Vol 70, Num 25, pp 10588-10591, issn 0022-3263, 4 p.Article

Hematologic side effects of interferon and ribavirin therapyKOWDLEY, Kris V.Journal of clinical gastroenterology. 2005, Vol 39, Num 1, pp S3-S8, issn 0192-0790, SUPArticle

Nucleoside analogues toxicities related to mitochon drial dysfunction : focus on HIV-infected childrenVIGANO, Alessandra; GIACOMET, Vania.Antiviral therapy (London). 2005, Vol 10, pp M53-M64, issn 1359-6535, SUP2Conference Paper

Factors contributing to ribavirin-induced anemiaNOMURA, Hideyuki; TANIMOTO, Hironori; HAYASHI, Jun et al.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 11, pp 1312-1317, issn 0815-9319, 6 p.Article

Efficient synthesis of 2'-C-β-methylguanosineLI, Nan-Sheng; PICCIRILLI, Joseph A.Journal of organic chemistry. 2006, Vol 71, Num 10, pp 4018-4020, issn 0022-3263, 3 p.Article

Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experienceJOLY, Véronique; YENI, Patrick.Antiviral therapy (London). 2005, Vol 10, Num 1, pp 29-40, issn 1359-6535, 12 p.Article

In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replicationKERN, Earl R; KUSHNER, Nicole L; HARTLINE, Caroll B et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 3, pp 1039-1045, issn 0066-4804, 7 p.Article

Elastic positively-charged liposomes for topical administration of acyclovirPEIRA, E; TROTTA, M; CARLOTTI, M. E et al.Journal of drug delivery science and technology. 2007, Vol 17, Num 5, pp 321-324, 4 p.Article

A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignanciesLEE, Chooi P; DE JONGE, Maja J. A; KAYE, Stan B et al.Clinical cancer research. 2006, Vol 12, Num 9, pp 2841-2848, issn 1078-0432, 8 p.Article

Rosacea fulminans related to pegylated interferon Alpha-2b and ribavirin therapyBETTOLI, Vincenzo; MANTOVANI, Lucia; BOCCIA, Sergio et al.Acta dermato-venereologica. 2006, Vol 86, Num 3, pp 258-259, issn 0001-5555, 2 p.Article

Single-day, patient-initiated famciclovir therapy for recurrent genital herpes : A randomized, double-blind, placebo-controlled trialAOKI, Fred Y; TYRING, Stephen; DIAZ-MITOMA, Francisco et al.Clinical infectious diseases. 2006, Vol 42, Num 1, pp 8-13, issn 1058-4838, 6 p.Article

Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis : A randomized, double-blind, placebo-controlled, clinic-initiated trialMORREL, Eric M; SPRUANCE, Spotswood L; GOLDBERG, Dennis I et al.Clinical infectious diseases. 2006, Vol 43, Num 4, pp 460-467, issn 1058-4838, 8 p.Article

An improved thermoanalytical approach to quantifying trace levels of polymorphic impurity in drug powdersTONG, Henry H. Y; SHEKUNOV, Boris Y; CHAN, John P et al.International journal of pharmaceutics. 2005, Vol 295, Num 1-2, pp 191-199, issn 0378-5173, 9 p.Article

Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirinKRAUS, Michael R; SCHÄFER, Arne; WISSMANN, Saskia et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 1, pp 90-100, issn 0009-9236, 11 p.Article

Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes : A randomized, double-blind, controlled trialSACKS, Stephen L; AOKI, Fred Y; MARTEL, Alain Y et al.Clinical infectious diseases. 2005, Vol 41, Num 8, pp 1097-1104, issn 1058-4838, 8 p.Article